Temporal changes of major protein concentrations in preterm and term human milk. A prospective cohort study.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
08 2019
Historique:
received: 20 04 2018
revised: 24 06 2018
accepted: 11 07 2018
pubmed: 11 8 2018
medline: 4 9 2020
entrez: 11 8 2018
Statut: ppublish

Résumé

Proteins are major contributors to the beneficial effects of human milk (HM) on preterm infant health and development. Alpha-lactalbumin, lactoferrin, serum albumin and caseins represent approximately 85% of the total HM protein. The temporal changes of these proteins in preterm (PT) HM and its comparison with term (T) HM is poorly characterized. To quantify and compare the temporal changes of the major proteins in PT HM and T HM. HM was collected for 4 months postpartum at 12 time points for PT HM (gestational age 28 0/7-32 6/7 weeks; 280 samples) and for 2 months postpartum at 8 time points for T HM (gestational age 37 0/7-41 6/7 weeks; 220 samples). Proteins were measured with a micro-fluidic LabChip system. Casein, alpha-lactalbumin and lactoferrin decreased with advancing stages of lactation in PT and T HM, whereas serum albumin remained stable. Only marginal differences between PT and T HM were observed for alpha-lactalbumin during postpartum weeks 3-5 and for serum albumin at the first week. However, a comparison of HM provided to preterm and term infants at the same postmenstrual ages revealed that alpha-lactalbumin contents were significantly lower in PT HM than in T HM during the 39-48 postmenstrual weeks. This study provides comprehensive information of the longitudinal changes of major proteins in PT and T HM, and suggests limited availability of alpha-lactalbumin, a nutritionally important protein, in breastfed PT infants after reaching the term corrected age. This information may be important to optimize HM protein fortification, although its biological relevance needs to be confirmed by intervention studies. ClinicalTrials.gov (NCT02052245), https://clinicaltrials.gov/ct2/show/NCT02052245.

Sections du résumé

BACKGROUND
Proteins are major contributors to the beneficial effects of human milk (HM) on preterm infant health and development. Alpha-lactalbumin, lactoferrin, serum albumin and caseins represent approximately 85% of the total HM protein. The temporal changes of these proteins in preterm (PT) HM and its comparison with term (T) HM is poorly characterized.
AIMS
To quantify and compare the temporal changes of the major proteins in PT HM and T HM.
METHODS
HM was collected for 4 months postpartum at 12 time points for PT HM (gestational age 28 0/7-32 6/7 weeks; 280 samples) and for 2 months postpartum at 8 time points for T HM (gestational age 37 0/7-41 6/7 weeks; 220 samples). Proteins were measured with a micro-fluidic LabChip system.
RESULTS
Casein, alpha-lactalbumin and lactoferrin decreased with advancing stages of lactation in PT and T HM, whereas serum albumin remained stable. Only marginal differences between PT and T HM were observed for alpha-lactalbumin during postpartum weeks 3-5 and for serum albumin at the first week. However, a comparison of HM provided to preterm and term infants at the same postmenstrual ages revealed that alpha-lactalbumin contents were significantly lower in PT HM than in T HM during the 39-48 postmenstrual weeks.
CONCLUSIONS
This study provides comprehensive information of the longitudinal changes of major proteins in PT and T HM, and suggests limited availability of alpha-lactalbumin, a nutritionally important protein, in breastfed PT infants after reaching the term corrected age. This information may be important to optimize HM protein fortification, although its biological relevance needs to be confirmed by intervention studies.
CLINICAL TRIAL REGISTRY
ClinicalTrials.gov (NCT02052245), https://clinicaltrials.gov/ct2/show/NCT02052245.

Identifiants

pubmed: 30093147
pii: S0261-5614(18)31218-4
doi: 10.1016/j.clnu.2018.07.016
pii:
doi:

Substances chimiques

Milk Proteins 0

Banques de données

ClinicalTrials.gov
['NCT02052245']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1844-1852

Informations de copyright

Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Auteurs

Clara L Garcia-Rodenas (CL)

Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland. Electronic address: clara.garcia@rdls.nestle.com.

Carlos A De Castro (CA)

Clinical Development Unit, Nestlé Research Asia, CADC, Singapore.

Rosemarie Jenni (R)

Nestlé Institute of Food Safety & Analytical Science, Nestlé Research, Lausanne, Switzerland.

Sagar K Thakkar (SK)

Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.

Lydie Beauport (L)

Clinic of Neonatology, Department Woman Mother Child, University Hospital of Lausanne, Switzerland.

Jean-François Tolsa (JF)

Clinic of Neonatology, Department Woman Mother Child, University Hospital of Lausanne, Switzerland.

Céline J Fischer-Fumeaux (CJ)

Clinic of Neonatology, Department Woman Mother Child, University Hospital of Lausanne, Switzerland.

Michael Affolter (M)

Nestlé Institute of Food Safety & Analytical Science, Nestlé Research, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH